On Monday, U.S. stocks experienced a rebound, with the Nasdaq Composite rising by 0.1%, while the S&P 500 and Dow Jones Industrial Average each recorded a slight dip of 0.1%. This...
(Reuters) -Royalty Pharma said on Thursday it has purchased additional royalties on Roche and PTC Therapeutics (NASDAQ:PTCT)' oral spinal muscular atrophy (SMA) drug for an...
Swiss pharmaceutical giant Roche Holding AG (OTC:RHHVF) has seen a 6% decrease in sales for the first three quarters of this year, a slump that has triggered a 3.2% drop in shares....
Shares of Tempest Therapeutics exhibited a notable surge on Wednesday, following the release of encouraging study results. The biopharmaceutical company's drug combination of...
By Ankika Biswas and Shashwat Chauhan (Reuters) -European shares closed off their day's highs on Wednesday on growing evidences of slowing economic activity in the continent,...
Investing.com -- U.S. futures inched lower, led by technology shares as a Wall Street Journal report of new curbs on artificial intelligence chip sales to China weighed. Here are...
Investing.com - European stock markets traded lower Wednesday, with worries about the health of the global banking system weighing as the earnings season continues at a pace. At...
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
2
13.11.2020.
CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza.
This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
0
Just like Biolidics. they get approval for Covid19 tests kits in USA
0
i dont know
0
is the historical price adjusted for stock splits?